Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Mier

Showing results (61-70 of 181) with videos related to

Pageof 19
Sort By:
The Biochemical Journal|December 19, 2023
Non-cross-linking advanced glycation end products affect prohormone processingSebastian Brings, Walter Mier, Barbro Beijer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2007
Influence of chelate conjugation on a newly identified tumor-targeting peptideWalter Mier, Sabine Zitzmann, Susanne Krämer, et al.
EJNMMI Research|June 8, 2012
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancerMartin Schäfer, Ulrike Bauder-Wüst, Karin Leotta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2013
Pharmacokinetic properties of peptidic radiopharmaceuticals: reduced uptake of (EH)3-conjugates in important organsMatthias Eder, Thomas Löhr, Ulrike Bauder-Wüst, et al.
Molecular Imaging and Biology|July 14, 2012
Peptide-based targeting of the platelet-derived growth factor receptor betaVasileios Askoxylakis, Annabell Marr, Annette Altmann, et al.
Journal of Medicinal Chemistry|December 13, 2002
Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural elementMichael Eisenhut, Ashour Mohammed, Walter Mier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2002
Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPETMarcus Henze, Ashour Mohammed, Heinz Schlemmer, et al.
Chemico-Biological Interactions|March 3, 2010
In vitro anticancer studies of alpha- and beta-D-glucopyranose betulin anomersHarish Kommera, Goran N Kaluderović, Martin Bette, et al.
Nuclear Medicine and Biology|November 9, 2010
Multivalent cyclic RGD ligands: influence of linker lengths on receptor bindingHolger Kubas, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
Repeated <sup>177</sup>Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBqHendrik Rathke, Frederik L Giesel, Paul Flechsig, et al.
Pageof 19

Showing results (61-70 of 181) with videos related to

Sort By:
Pageof 19
The Biochemical Journal|December 19, 2023
Non-cross-linking advanced glycation end products affect prohormone processingSebastian Brings, Walter Mier, Barbro Beijer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2007
Influence of chelate conjugation on a newly identified tumor-targeting peptideWalter Mier, Sabine Zitzmann, Susanne Krämer, et al.
EJNMMI Research|June 8, 2012
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancerMartin Schäfer, Ulrike Bauder-Wüst, Karin Leotta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2013
Pharmacokinetic properties of peptidic radiopharmaceuticals: reduced uptake of (EH)3-conjugates in important organsMatthias Eder, Thomas Löhr, Ulrike Bauder-Wüst, et al.
Molecular Imaging and Biology|July 14, 2012
Peptide-based targeting of the platelet-derived growth factor receptor betaVasileios Askoxylakis, Annabell Marr, Annette Altmann, et al.
Journal of Medicinal Chemistry|December 13, 2002
Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural elementMichael Eisenhut, Ashour Mohammed, Walter Mier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2002
Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPETMarcus Henze, Ashour Mohammed, Heinz Schlemmer, et al.
Chemico-Biological Interactions|March 3, 2010
In vitro anticancer studies of alpha- and beta-D-glucopyranose betulin anomersHarish Kommera, Goran N Kaluderović, Martin Bette, et al.
Nuclear Medicine and Biology|November 9, 2010
Multivalent cyclic RGD ligands: influence of linker lengths on receptor bindingHolger Kubas, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
Repeated <sup>177</sup>Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBqHendrik Rathke, Frederik L Giesel, Paul Flechsig, et al.
Pageof 19